GPX4 Activation as Neuroprotective Strategy
🧪 Overview
Direct pharmacological activation of GPX4 would inhibit ferroptosis in cerebral microvascular cells, preserving tight junction complexes. However, no bona fide GPX4 activator with proven BBB penetration, appropriate PK, or safety profile exists. GPX4 activation is likely limited by substrate availability (GSH depletion) or oxidative inactivation post-cardiac arrest. The causal chain from 'activation' to 'protection' requires multiple unproven links. This hypothesis is 'promising mechanism awaiting tool compound' rather than testable therapeutic hypothesis.
🧬 Mechanism
Curated pathway from expert analysis
flowchart TD
A["GPX4 glutathione peroxidase 4<br/>Hypothesis Target"]
B["Ferroptosis<br/>Cited Mechanism"]
C["Cellular Response<br/>Stress or Clearance Change"]
D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
E["Neurodegeneration<br/>Disease-Relevant Outcome"]
A --> B
B --> C
C --> D
D --> E
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — GPX4
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for GPX4 (glutathione peroxidase 4) from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GPX4 (glutathione peroxidase 4).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
🔮 Predictions
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF GPX4 is conditionally deleted specifically in cerebral endothelial cells using Cdh5-CreERT2;Gpx4^flox/flox mice AND these mice undergo cardiac arrest (KCl-induced, 5 min asphyxiation model) with re | Significant loss of tight junction integrity (ZO-1 immunofluorescence: ≤40% of control intensity; EB dye concentration in brain parenchyma: ≥0.5 μg/g tissue) in | — no observation — | pending | 0.38 |
| IF primary cerebral microvascular endothelial cells are pretreated with N-acetylcysteine (NAC, 1 mM, 24h) to elevate glutathione substrate availability AND then exposed to oxygen-glucose deprivation ( | Increased GPX4 activity (nmol NADPH/min/mg protein) and reduced ferroptosis markers (4-HNE: ≤2.5-fold vs. normoxia baseline; lipid ROS: ≤1.5-fold vs. normoxia) | — no observation — | pending | 0.45 |
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |